Association between inflammation, lipid and hemostatic factors in patients with stable angina

Thrombosis Research

Volumn 120, Issue 1, 2007, Pages 53-59

  Sagastagoitia, José D ^a   Sáez, Yolanda ^b   Vacas, Marta ^b   Narváez, Idoia ^b   Sáez de Lafuente, Jesús P ^c   Molinero, Enrique ^a   Magro, Ana ^b   Lafita, Manuel ^b   Santos, Mónica ^b   Escobar, Antonio ^a   Iriarte, José A ^b  

^a HOSPITAL DE BASURTO   (Spain)

^b Fundacion para la Investigacion Y Docencia de Las Enfermedades Cardiovasculares (FIDEC)   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

Author keywords

Hemostatic factors; Inflammation; Lipids; Stable angina; Thrombosis

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B100; C REACTIVE PROTEIN; CHOLESTEROL; D DIMER; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARITHMETIC; ARTICLE; CARDIAC PATIENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; ANGINA PECTORIS; APOLIPOPROTEIN A-I; APOLIPOPROTEIN B-100; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 34247334677     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2006.06.013     Document Type: Article

References (30)

1. Haverkate F., Thompson S.G., Pyke S.D.M., Gallimore J.R., and Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Lancet 349 (1997) 462-466
2. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
3. Koenig W. Fibrinogen in cardiovascular disease: an update. Thromb Haemost 89 (2003) 601-609
4. Koenig W., Rothenbacher D., Hoffmeister A., Griesshammer M., and Brenner H. Plasma fibrin D-dimer levels and risk of stable coronary artery disease. Results of a large case-control study. Arterioscler Thromb Vasc Biol 21 (2001) 1701-1705
5. Moss A.J., Goldstein R.E., Marder V.J., Oakes Ch.E., Greenberg D., Weiss H., et al. Thrombogenic factors and recurrent coronary events. Circulation 99 (1999) 2517-2522
6. Spronk H., van der Voort D., and Ten Cate H. Blood coagulation and the risk of atherothrombosis: a complex relationship. Thromb J 2 (2004) 12-20
7. Sambola A., Fuster V., and Badimon J.J. Role of coronary risk factors in blood thrombogenicity and acute coronary syndromes. Rev Esp Cardiol 56 (2003) 1001-1009
8. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 (2004) 1387-1389
9. Becker R.C., Cannon C.P., Bovill E.G., Tracy R.P., Thompson B., Knatterud G.L., et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial). Am J Cardiol 78 (1996) 142-147
10. Held C., Hjemdahl P., Rehnqvist N., Wallen N.H., Forslund L., Bjorkander I., et al. Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study in Stockholm (APSIS). A comparison with healthy controls. J Intern Med 241 (1997) 59-69
11. Ridker P.M., and Cook N. Clinical usefulness of very high and very low levels of C-reactive protein across the full range of Framingham Risk Scores. Circulation 109 (2004) 1955-1959
12. Mori T., Sasaki J., Kawaguchi H., Handa K., Takada Y., Matsunaga A., et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129 (1995) 234-238
13. ECAT Angyna Pectoris Study Group. Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J 14 (1993) 8-17
14. Hoffmeister A., Rothenbacher D., Bazner U., Frohlich M., Brenner H., Hombach V., et al. Role of novel markers of inflammation in patients with stable coronary heart disease. Am J Cardiol 87 (2001) 262-266
15. Renate M., Holm K., and Hübner P. Introducción a los métodos de la sociología empírica (1985), Alianza Editorial, Madrid 89
16. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352 (2005) 1685-1695
17. Kuller T.H., Tracy R.P., Shaten J., and Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial. Am J Epidemiol 144 (1996) 537-547
18. Zebrak J.S., et al., for the Intermountain Heart Collaboration Study Group. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. Am J Coll Cardiol 39 (2002) 632-637
19. Erren M., Reinecke H., Junker R., Fobker M., Schulte H., Schurek J.O., et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19 (1999) 2355-2363
20. Rifai N., Joubran R., Yu H., Asmi M., and Jouma M. Inflammatory markers in men with angiographycally documented coronary heart disease. Clin Chem 45 (1999) 1967-1973
21. Veselka J., Prochazkova S., Duchonova R., Bolomova I., UrbanovaTesar T., Tesar D., et al. Relationship of C-reactive protein to presence and severity of coronary atherosclerosis in patients with stable angina pectoris or a pathological exercise test. Coron Artery Dis 13 (2002) 151-154
22. Erbagci A.B., Tarakcioglu M., Aksoy M., Kovacas R., Nacak M., Aynacioglu A.S., et al. Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol 57 (2002) 197-204
23. Taniguchi H., Momiyama Y., Ohmori R., Yonemura A., Yamashita T., Tamai S., et al. Association of plasma C-reactive levels with the presence and extent of coronary stenosis in patients with stable coronary artery disease. Atherosclerosis 178 (2005) 173-177
24. Viles-Gonzales J.F., Fuster V., and Badimon J.J. Atherothrombosis. A widespread disease with unpredictable and life threatening consequences. Eur Heart J 25 (2004) 1197-1207
25. Harb T.S., Zareba W., Moss A.J., Ridker P.M., Rifai N., Marder V.J., et al. Association between inflammatory markers, hemostatic and lipid factors in post infarction patients. Am J Cardiol 91 (2003) 1120-1123
26. Rohde L.E., Hennekens C.H., and Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 84 (1999) 1018-1022
27. Chenaud C., Merlani P.G., Roux-Lombard P., Burger D., Harbarth S., Luyasu S., et al. Low apolipoprotein A-1 level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med 32 (2004) 632-637
28. Sampietro T., Bigazzi F., Dal Pino B., Fusaro S., Greco F., Tuoni M., et al. Increased plasma C-reactive protein in familial hypoalphalipoproteinemia: a proinflammatory condition?. Circulation 105 (2002) 11-14
29. Mostaza J.M., Camino N., Gómez Gerique J., Peña R., Baquero M., and Lahos C. C-reactive protein levels and prevalence of chronic infections in subjects with hypoalphalipoproteinemia. Metab Clin Exp 54 (2005) 33-37
30. β and tumour necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 97 (2001) 2381-2389